| Name | Title | Contact Details |
|---|
At VMG Health, were more than just a team of experts; were trusted partners in the business of healthcare. Backed by a team of over 300 professionals and a history of more than 70,000 engagements since 1995, we bring experience deep and wide to every project. Our national client base ranges from large health systems to small practices and everything in between, including investors and private equity firms. Our solutions-oriented approach to client needs is bolstered by our strong market position, extensive contacts, unparalleled tools and solutions, and expert insights. We are proud to serve as the single source for all our clients valuation, strategic, and compliance needs. At VMG Health, we make healthcare business performance personal.
About Kotak Mahindra Group: Established in 1985, the Kotak Mahindra Group is one of Indias leading financial services conglomerates. In February 2003, Kotak Mahindra Finance Ltd. (KMFL), the Groups flagship company, received a banking license from the Reserve Bank of India (RBI). With this, KMFL became the first non-banking finance company in India to become a bank – Kotak Mahindra Bank Limited. The consolidated balance sheet of Kotak Mahindra Group is over 1 lakh crore and the consolidated net worth of the Group stands at 13,943 crore (approx US$ 2.6 billion) as on September 30, 2012. The Group offers a wide range of financial services that encompass every sphere of life. From commercial banking, to stock broking, mutual funds, life insurance and investment banking, the Group caters to the diverse financial needs of individuals and the corporate sector. The Group has a wide distribution network through branches and franchisees across India, and international offices in London, New York, California, Dubai, Abu Dhabi, Bahrain, Mauritius and Singapore. For more information, please visit the companys website at http://www.kotak.com
Seramount is a New York-based management consulting firm that provides diversity, equity and inclusion advisory services for businesses.
HAIMER is a family run, medium sized company located in Igenhausen, Bavaria near Munich, Germany. We design, produce and sell innovative, high precision products for metal cutting as well as for other branches including automotive, aerospace, energy, rail and general machining. In addition to our large offering of tool holders in all popular interfaces and lengths, including our shrinking and balancing machines, as well as our 3-D Sensors and solid carbide cutting tools, our product offering also includes tool presetting machines of HAIMER Microset. Out of approx. 800 employees worldwide, 500 work at our main production facility in Igenhausen together with the most modern of machines and a high level of automation. At our second HAIMER production site in Bielefeld with around 50 employees, HAIMER Microset presetting machines are manufactured. Our experienced, dynamic and highly qualified employees guarantee the well-known and highest quality "made by HAIMER." As an active apprenticeship company with almost 50 apprentices and a high internal acquisition rate, HAIMER is able to secure its future skilled employees and to fulfill its contribution to further educate young adults, as well as securing the future of our German manufacturing location. As the European market leader in the area of tool holding technology, with a daily capacity of max. 4,000 tool holders, keeping the technological edge of our products is very important to us. Because of this, every year we invest between 8 and 10% of our revenue in research and development. Every day we desire to be better and that works perfectly with our corporate philosophy: Quality Wins Imprint Provider/Responsible for the Haimer GmbH website: Haimer GmbH Weiherstr. 21 D-86568 Igenhausen E-mail: haimer@haimer.de Web: www.haimer.com Also: Youtube Xing CEO: Franz Haimer, Claudia Haimer, Andreas Haimer Corporate headquarters: Igenhausen Commercial register: Amtsgericht Augsburg, HRB 8679 VAT ID number: DE 127333346
Synonym is accelerating the worlds biological future by developing, financing and building commercial-scale biomanufacturing facilities. We provide synthetic biology (synbio) producers – from startups to the Fortune 500 – with flexible production capacity while giving infrastructure investors access to a new, carbon-negative biomanufacturing asset class that we are calling "fermentation farms".